Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
axhidrox 2,2 mg/pumpning kräm
dr. august wolff gmbh & co arzneimittel - glykopyrroniumbromid - kräm - 2,2 mg/pumpning - glykopyrroniumbromid 2,7 mg aktiv substans; propylenglykol hjälpämne; cetostearylalkohol hjälpämne; bensylalkohol hjälpämne
Finland -
svenska -
Ecolab
solidsense all purpose super concentrate (916561)
ecolab deutschland gmbh -
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
clariscan 0,5 mmol/ml injektionsvätska, lösning
ge healthcare as - gadoterinsyra - injektionsvätska, lösning - 0,5 mmol/ml - gadoterinsyra 279,32 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
clariscan 0,5 mmol/ml injektionsvätska, lösning i förfylld spruta
ge healthcare as - gadoterinsyra - injektionsvätska, lösning i förfylld spruta - 0,5 mmol/ml - gadoterinsyra 279,32 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
bayticol vet. 10 mg/ml pour-on, lösning
bayer animal health gmbh - flumetrin - pour-on, lösning - 10 mg/ml - flumetrin 10 mg aktiv substans; butylhydroxitoluen hjälpämne - flumetrin - får, nöt
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
bayticol vet. 10 mg/ml pour-on, lösning
orifarm ab - flumetrin - pour-on, lösning - 10 mg/ml - flumetrin 10 mg aktiv substans; butylhydroxitoluen hjälpämne - får, nöt
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
vydura
pfizer europe ma eeig - rimegepant - migrän störningar - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.